At Tempus, we are on a mission to redefine how genomic data is used in a clinical setting. Our goal is for each patient to benefit from the treatment of others who came before by providing physicians with tools that learn as we gather more data.
Cancer isn't only about where it grows. It's about how it grows. Genetic alterations drive cancer growth. Some treatments address these specific alterations. Tempus helps doctors identify the treatments that might work for your unique cancer.
Eric Lefkofsky is the co-founder and CEO at Tempus. He is a founding partner of Lightbank, a venture fund investing in disruptive technology businesses. He is also the co-founder of Uptake Technologies, a leading predictive analytics platform for the world’s largest industries; Mediaocean, a leading provider of integrated media procurement technology; Echo Global Logistics (NASDAQ: ECHO), a technology-enabled transportation and logistics outsourcing firm; and InnerWorkings (NASDAQ: INWK), a global provider of managed print and promotional solutions. He co-chairs the Lefkofsky Family Foundation with his wife Liz to advance high-impact initiatives that enhance lives in the communities served. Lefkofsky serves as a Trustee of Lurie Children’s Hospital of Chicago, The Art Institute of Chicago, The Museum of Science and Industry and World Business Chicago. He is also Chairman of the Board of Trustees of Chicago’s Steppenwolf Theatre Company. Lefkofsky is an adjunct professor at the University of Chicago and author of Accelerated Disruption: Understanding the True Speed of Innovation. He graduated from the University of Michigan and received his Juris Doctor at University of Michigan Law School. For more information, visit lefkofsky.com, connect on LinkedIn and follow him on Twitter (@lefkofsky) and Facebook (@eplefkofsky).
RDLS FEED LINKS
MINDS SOCIAL NETWORK
Minds: The New, Super-Private, Super-Open Social Network. Full blog @